GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » COGS-to-Revenue

Greenbrook TMS (Greenbrook TMS) COGS-to-Revenue : 1.12 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS COGS-to-Revenue?

Greenbrook TMS's Cost of Goods Sold for the three months ended in Mar. 2024 was $20.19 Mil. Its Revenue for the three months ended in Mar. 2024 was $18.01 Mil.

Greenbrook TMS's COGS to Revenue for the three months ended in Mar. 2024 was 1.12.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Greenbrook TMS's Gross Margin % for the three months ended in Mar. 2024 was -12.10%.


Greenbrook TMS COGS-to-Revenue Historical Data

The historical data trend for Greenbrook TMS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS COGS-to-Revenue Chart

Greenbrook TMS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.76 0.88 0.89 1.04 1.00

Greenbrook TMS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 0.86 0.60 2.29 1.12

Greenbrook TMS COGS-to-Revenue Calculation

Greenbrook TMS's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=73.817 / 73.787
=1.00

Greenbrook TMS's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=20.191 / 18.012
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenbrook TMS  (OTCPK:GBNHF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Greenbrook TMS's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 20.191 / 18.012
=-12.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Greenbrook TMS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenbrook TMS (Greenbrook TMS) Business Description

Traded in Other Exchanges
N/A
Address
890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4
Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.

Greenbrook TMS (Greenbrook TMS) Headlines